Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.065 | 0.8 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |